Episode Details

Christopher O’Connor has stepped down as CEO of Yale New Haven Health after leading the system since 2022, marking the end of a 14-year climb through executive ranks. Under his leadership, the health system expanded significantly, integrated multiple hospitals, and weathered major challenges including rising costs, restructuring, and a costly cybersecurity settlement. Pamela Sutton-Wallace, who became president in 2024, will now serve as acting CEO. O’Connor will remain in a special advisory role as the system prepares to launch its most ambitious project yet: the $838 million Adams Neurosciences Center, set to open next year. A nationwide search is underway to find his permanent successor, signaling a pivotal new chapter for one of the nation’s most prominent academic health systems.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9a383fdd1c99e8d6